Hematology
Rh Alloimmunization Explored in Chronically Transfused Thalassemia Patients

Chronic life-long transfusions are often required for patients with severe thalassemia to provide normal red blood cells and to suppress the patients’ own ineffective erythropoiesis.
Product Showcase
Latest Hematology News
- Next Generation Sequencing Finds More Gene Mutations for Leukemia
- Biomarker Predicts Pancreatic Cancer Patients’ Response to CD40 Immunotherapy
- Automated Leucocyte VCS Parameters Evaluated for Pathogenic Infections
- TFP Inhibitor Levels Elevated in Bleeding Tendency Patients
- RDW Levels Associated with Adverse Outcomes in COVID-19 Patients